The increased risk of drug errors and contamination of multi-dose vials is expected to propel the growth of the pre-filled saline syringe market. Prefilled syringes offer many advantages and are commonly used for cleaning all vascular access devices. Prevents infection and cross-contamination due to repeated use of unit dose and multi-dose vials used in a large amount of saline bag.
Pre-filled saline syringes are designed to help reduce contamination and prevent solution from re-entering the non-sterile portion of the syringe. These syringes are manufactured according to ISMP drug labeling and help reduce drug errors.
Medication error refers to treatment failure due to underprescription, irrational/inappropriate prescription, or overprescription. Sometimes, drug errors are caused by contamination, impurities, incorrect packaging, or incorrect impurities.
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/22660
All prefilled saline syringes are disposable devices and are not provided with preservatives of any kind. This attempt is used to save time and money for the end user and is integrated with two sterilization processes: terminal sterilization and aseptic sterilization. This sterilization process is intended to ensure the safety of the product from contamination.
Patient safety is now receiving well-defined attention to improve quality of life, which presents significant opportunities for manufacturing companies. Prefilled syringes are preferred over conventional vials because they increase the demand for prefilled syringes by promoting a number of advantages such as reduced overfilling, safe and convenient use.
Pre-filled syringe saline delivery is convenient for patients who require daily or weekly parenteral administration and long-term treatment. As they are designed for patient acceptance and compliance, the demand for pre-filled syringes is increasing. Advances in technology have made injections more user-friendly and easier to perform.
This has motivated patients and physicians to adopt prefilled syringes in chronic diseases and other lifestyle-related diseases. Prefilled syringes are mostly disposable and are disposable as an additional layer of protection, which is costly and prevents counterfeiting. The tamper-proof packaging makes it difficult to access the basic packaging without destroying the device.
According to WHO estimates, around 30% of drugs sold in developing countries and parts of Asia, Africa and Latin America are fraudulent. Packaging technology for prefilled syringes is rapidly evolving with new polymers that are less likely to extract and leach and better protect the drug.
Request Table of Contents @ https://www.persistencemarketresearch.com/toc/22660
The global market for pre-filled saline syringes is driven by increasing adoption to reduce cross-contamination of drugs. Additionally, the rise in home care and self-injecting drugs to avoid hospital visits has increased healthcare spending worldwide and is expected to boost the market.
According to OECD Health at Glance 2017, health spending in the OECD was approximately US$4,000 per capita, while US spending accounted for nearly US$10,000 per capita. Other factors, such as the availability of a well-developed manufacturing infrastructure and the low-cost labor associated with manufacturing prefilled syringes, have shifted the trend of outsourcing empty prefilled syringe manufacturing to in-house prefilled syringe manufacturing.
This strategy has enabled the company to increase its profitability in the marketplace. In June 2013 Roselabs Biosciences opened a Rupees 400cr pre-filled syringe unit in Ahmedabad to manufacture empty PFS.
The 3-injector, 5-injector, and 10-injector types occupy a significant portion of the market. The 3 and 10 syringe type segments hold a large revenue share in the market overall. This is due to the high adoption rate of the end-user segment. Additionally, cross-contamination, dosing errors, and recognition of the benefits of prefilled saline syringes over traditional syringes have led to strong positioning of these segments in the overall market.
The hospital and clinic sector holds a strong position in the market due to the high penetration of pre-filled syringes due to increasing medical problems and changes in government regulations to minimize treatment errors. These end-user segments have a significant revenue share in the overall market.
However, the continued growth of home care settings to reduce hospitalization is expected to propel the growth of the pre-filled saline syringe market. Additionally, increasing awareness among end users to increase patient compliance is expected to propel the growth of the prefilled saline syringes market.
Geographically, the global prefilled saline syringe market is segmented into five major regions. North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America is expected to become the dominant region in the global market due to its high penetration rate among customers as well as end users. Europe is projected to hold the second largest market share in the global pre-filled saline syringe market owing to rising awareness.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/22660
Competitive Outlook
Some of the players identified in the global prefilled saline syringes market include Becton, Dickinson and Company, Cardinal Health, MedXL Inc., Guerbet SA, and others. A growing interest in the growing demand for efficient saline delivery is expected in various developed countries. Drive demand for efficient, advanced medical equipment.
Pre-filled syringes reduce dosing errors, increase patient compliance, increase dosing accuracy, convenience and safety, and reduce time spent in medical centers. Increasing government funding for advanced medical treatments and targeted delivery research in consideration of patient safety is expected to drive revenue growth in the global pre-filled saline syringe market.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – www.persistencemarketresearch.com